Impact, strategies, and opportunities for early and midcareer cardiovascular researchers during the COVID-19 pandemic

The coronavirus 2019 (COVID-19) pandemic, resulting in the shutdown of laboratory and clinical cardiovascular research and postponement or cancellation of many scientific conferences, will likely have a substantial effect on the career progression of researchers on a global scale. Early and midcareer researchers (EMCRs) are particularly vulnerable, given the disruption in establishing research independence, developing their team, building their reputation within the scientific community, and attracting research funding, which can be challenging for EMCRs, who historically have lower funding success rates compared with more senior researchers.